?

Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Found 16384 publications
CymaBay Therapeutics, Inc. - Product Pipeline Review - 2015 US$ 1,500.00

... pipeline projects Latest company statement Latest news and deals relating to the CymaBay Therapeutics, Inc.’s pipeline products Reasons to buy Evaluate CymaBay Therapeutics, Inc ...

May, 2015 29 pages
Cerenis Therapeutics Holding SA - Product Pipeline Review - 2015 US$ 1,500.00

... pipeline projects Latest company statement Latest news and deals relating to the Cerenis Therapeutics Holding SA’s pipeline products Reasons to buy Evaluate Cerenis Therapeutics Holding ...

May, 2015 31 pages
ATLAB Pharma SAS - Product Pipeline Review - 2015 US$ 1,500.00

... portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the ATLAB Pharma SAS’s pipeline ...

May, 2015 22 pages
Global and Chinese Pharmaceutical Grade Potassium Chloride Industry, 2015 Market Research Report US$ 2,800.00

... 'Global and Chinese Pharmaceutical Grade Potassium Chloride Industry, 2010-2020 Market Research Report' is a professional and in-depth study on the current state of the global Pharmaceutical Grade Potassium ... project of Pharmaceutical Grade Potassium Chloride Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2010-2020 global and Chinese Pharmaceutical Grade Potassium ...

Jun, 2015 150 pages
Global and Chinese Pharmaceutical Grade Epsom Salt Industry, 2015 Market Research Report US$ 2,800.00

... 'Global and Chinese Pharmaceutical Grade Epsom Salt Industry, 2010-2020 Market Research Report' is a professional and in-depth study on the current state of the global Pharmaceutical Grade Epsom ... project of Pharmaceutical Grade Epsom Salt Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2010-2020 global and Chinese Pharmaceutical Grade Epsom ...

Jun, 2015 150 pages
Global and Chinese Insulin Pen Needle Industry, 2015 Market Research Report US$ 2,800.00

The 'Global and Chinese Insulin Pen Needle Industry, 2010-2020 Market Research Report' is a professional and in-depth study on the current state of the global Insulin Pen Needle ... project of Insulin Pen Needle Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2010-2020 global and Chinese Insulin Pen Needle industry ...

Jun, 2015 150 pages
Global and Chinese Insulin pen Industry, 2015 Market Research Report US$ 2,800.00

The 'Global and Chinese Insulin pen Industry, 2010-2020 Market Research Report' is a professional and in-depth study on the current state of the global Insulin pen industry with a focus on the Chinese ...

Jun, 2015 150 pages
CIS Insulin Market (Rapid Acting, Short Acting, Pre-Mixed, Long Acting, Type I & II Diabetes, Analogs, Recombinant Insulin) Analysis And Segment Forecasts To 2020 US$ 4,700.00

... and ultra-fast acting analogs. For the purpose of this study, Grand View Research has segmented the CIS Insulin market on the basis of product, application, source and region: CIS Insulin Product Outlook Rapid Acting Long Acting Premixed Premixed Analog Short Acting Intermediate Acting CIS Insulin Application ...

Jul, 2014 82 pages
Latin America (Brazil, Argentina, Chile, Mexico, Colombia, Venezuela) Insulin Market (Rapid Acting, Short Acting, Pre-Mixed, Long Acting, Type I & II Diabetes, Analogs, Recombinant)... US$ 4,700.00

... the study suggest: Long acting products dominated insulin demand in Latin America, with estimated revenue of USD 548.6 million in 2013. Other leading ... Insulin Source Outlook Human Recombinant Analogs Insulin Regional Outlook Brazil Argentina Chile Mexico Colombia Venezuela Peru Rest of Latin America

Jun, 2014 84 pages
Asia Pacific (India, China, Australia, South Korea & Others) Insulin Market (Rapid Acting, Short Acting, Pre-Mixed, Long Acting, Type I & II Diabetes, Analogs & Recombinant Insulin)... US$ 4,700.00

... in insulin prices as a result of continued initiatives to improve healthcare access. The Asia Pacific insulin market is oligopolistic in nature and is dominated by three key players ... Human Recombinant Analogs Insulin Regional Outlook India China Australia New Zealand South Korea Taiwan Philippines Vietnam Indonesia Japan Malaysia Thailand Rest of Asia Pacific

May, 2014 80 pages
Insulin Market Analysis By Product (Fast Acting, Short Acting, Intermediate Acting, Pre-Mix and Long Acting), By Segments (Insulin Analogs And Human Recombinant Insulin), By Application... US$ 4,700.00

... factors expected to drive market growth. Emerging markets including Asia Pacific accounted for 26.5% of global revenue in 2013. Asia Pacific insulin market is expected to grow at the ... insulin market on the basis of product, segment (on the basis of source), application and region: Insulin Product Outlook Fast Acting Insulin Short Acting Insulin Intermediate Acting Insulin Long Acting Insulin ...

Apr, 2014 85 pages
Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2015 US$ 1,750.00

... Pipeline product profiles CAR-T Technologies and Targeted Antigens Licensing opportunities Market Drivers and Barriers Scope Overview of the global CAR-T cell therapy pipeline scenario, products and associated companies information Coverage of global CAR ...

Jul, 2015 120 pages
Investigation Report on China Piperacillin Sodium and Tazobactam Sodium Market, 2010-2019 US$ 2,000.00

... Wyeth Pharmaceutical Co., Ltd (US), Qilu Pharmaceutical Co., Ltd, North China Pharmaceutical Group Corporation, Zhejiang Anglikang Pharmaceutical Co., Ltd and United Laboratories occupy the majority of the Chinese market, among which Wyeth Pharmaceutical Co., Ltd ...

Jun, 2015 35 pages
Investigation Report on China Thrombin Market, 2010-2019 US$ 2,000.00

... thrombin in the Chinese market are Changchun Guoao Pharmaceutical Co., Ltd, Biochemical Pharmaceutical Factory of Zhuhai S. E. Z., Hunan Yige Pharmaceutical Co., Ltd, Hacon Pharma and Wuxi Kaifu Pharmaceutical Co., Ltd ...

Jun, 2015 35 pages
Investigation Report on China Risedronate Sodium Market, 2010-2019 US$ 2,000.00

... Risedronate sodiums in the Chinese market are all produced by local enterprises represented by Kunming Jida Pharmaceutical Co., Ltd, Topfond, Yangtze River Pharmaceutical Group, Jiangsu Chiatai Qingjiang Pharmaceutical Co., Ltd and Beijing SL Pharm, among which Kunming Jida Pharmaceutical Co., Ltd ...

Jun, 2015 30 pages
Investigation Report on China Simvastatin Market, 2010-2019 US$ 2,000.00

... Pharmaceutical Co., Ltd, Merck Sharp & Dohme (UK), Guangzhou Nanxin Pharmaceutical Co., Ltd, Sichuan Hairong Pharmaceutical Co., Ltd and Shandong Lukang Pharmaceutical Co., Ltd occupy the majority of market, among which Hangzhou MSD Pharmaceutical Co., Ltd ...

Jun, 2015 40 pages
Investigation Report on China Levofloxacin Market, 2010-2019 US$ 2,000.00

... Daiichi Sankyo Co., Ltd (Beijing), Yangtze River Pharmaceutical Group, China Resources Double Crane Pharmaceutical Co., Ltd, Santen Pharmaceutical Co., Ltd (Japan) and Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory have occupied the majority of the market share, among which Daiichi Sankyo ...

Jun, 2015 40 pages
Investigation Report on China Raloxifene Market, 2010-2019 US$ 2,000.00

... bone mass or osteoporosis while this figure is 30%-50% among women aged 60 and above. Raloxifene (raloxifene hydrochloride), a non-hormone drug against bone resorption, belongs to the second generation of selective estrogen receptor modulator (SERMs ...

Jun, 2015 30 pages
Investigation Report on China Sodium Ibandronate Market, 2010-2019 US$ 2,000.00

... China. Currently, sodium ibandronate market in China is mainly occupied by the following companies: Science & Technology General Company Hebei Medical University, Roche Diagnostics GmbH GE), Hencer Pharmacy and Easton Pharmaceutical Co., Ltd, among which Science & Technology General Company Hebei Medical ...

Jun, 2015 30 pages
Investigation Report on China Thymosin α1 Market, 2010-2019 US$ 2,000.00

... Diao Group, Suzhou Tianma Pharma Group Tianji BIO-pharmaceutical Co., Ltd and Hainan Shuangcheng Pharmaceuticals Co., Ltd, among which Diao Group has the largest market share of about 36% for sales volume in 2014. However, Patheon Italia ...

Jun, 2015 30 pages
Investigation Report on China Zoledronic Acid Market, 2010-2019 US$ 2,000.00

... Novartis (Switzerland), Chia Tai Tianqing Pharmaceutical Group Co., Ltd, Jiangsu Hengrui Medicine Co., Ltd, Sichuan Hairong Pharmaceutical Co., Ltd and Jilin Province Xidian Pharmaceutical Sci-Tech Development Co., Ltd occupy the majority of the market share, among which Novartis ...

Jun, 2015 30 pages
Investigation Report on China Cervus and Cucumis Polypeptide Market, 2010-2019 US$ 2,000.00

... cervus and cucumis polypeptide in the Chinese market all come from the following three companies: Gloria Pharmaceuticals Co., Ltd, Heilongjiang Dilong Pharmaceutical Co., Ltd and Heilongjiang Jiangshi Pharmaceutical Co., Ltd, among which Gloria Pharmaceuticals Co., Ltd ...

Jun, 2015 30 pages
Investigation Report on China Alendronate Sodium Market, 2010-2019 US$ 2,000.00

... Merck Sharp & Dohme (Italy), CSPC Ouyi Pharmaceutical Co., Ltd, Beijing Wansheng Pharmaceutical Co., Ltd, Haini Pharmaceutical Co., Ltd and Chengdu Tiantaishan Pharmaceutical Co., Ltd occupy the majority of market share, among which Merck Sharp & Dohme ...

Jun, 2015 30 pages
Investigation Report on China Sodium Hyaluronate Market, 2010-2019 US$ 2,000.00

... sodium hyaluronate injection is used as a joint function-improving agent for intra-articular injection on osteoarthropathy patients. Currently, only sodium hyaluronate injection ...

Jun, 2015 35 pages
Investigation Report on China Olanzapine Market, 2010-2019 US$ 2,000.00

... holergasia. Mental illness has surpassed cancer and become the biggest threat to human health, ranking first in the total burden of disease in China. As an atypical antipsychotic, olanzapine ... life brought about by China’s economic development, the incidence of mental illness and psychological problems is growing. Therefore, the market size of olanzapine in China is expected to keep expanding ...

Jun, 2015 25 pages
Investigation Report on China Paclitaxel Market, 2010-2019 US$ 2,000.00

... China paclitaxel market include Nanjing Luye Pharma Group Sike Pharmaceutical Co., Ltd, The Department of Cancer, Bristol-Myers Squibb ...

Jun, 2015 40 pages
Investigation Report on China Imipenem and cilastatin sodium Market, 2010-2019 US$ 2,000.00

... imipenem and cilastatin sodium in China competitive landscape of imipenem and cilastatin sodium in Chinese market price of imipenem and cilastatin sodium made by different enterprises in China market outlook of imipenem and cilastatin sodium in China ...

Jun, 2015 30 pages
Investigation Report on China Salmon Calcitonin Market, 2010-2019 US$ 2,000.00

... Novartis’s salmon calcitonin entered China under the trade name of Miacalcic and later salmon calcitonin made by Lisapharma ...

Jun, 2015 35 pages
Investigation Report on China Rosuvastatin Market, 2010-2019 US$ 2,000.00

... rosuvastatin (rosuvastatin calcium ... rosuvastatin in the Chinese market mainly come from the following companies: IPR Pharmaceuticals (US), Lunan Better Pharmaceutical Co., Ltd, Nanjing Chia Tai Tianqing, Simcere and Zhejiang Jingxin Pharmaceutical Co., Ltd, among which IPR Pharmaceuticals ...

Jun, 2015 35 pages
Investigation Report on China Progesterone Market, 2010-2019 US$ 2,000.00

... progesterone in the Chinese market is imported and made by Fleet (UK) and Capsugel(FR). The rest mainly comes from such local manufacturers as Asen, Zhejiang Xianju Pharmaceutical Co., Ltd ... steroid drugs will keep growing and that with the development of downstream products, the demand for progesterone ...

Jun, 2015 35 pages
Investigation Report on China Ossotide Market, 2010-2019 US$ 2,000.00

... of rheumatoid arthritis (RA) is 0.2%-0.36% and the number of cases is 5-10 million in China. Apart from RA, osteoarthritis, an expression of ... ossotide in China competitive landscape of ossotide in Chinese market price of ossotide made by different enterprises in China market outlook of ossotide in China ...

Jun, 2015 35 pages
Investigation Report on China Moxifloxacin Market, 2010-2019 US$ 2,000.00

... China are mainly produced by Nanjing Youke Pharmaceutical CO., Ltd and The Bayer Group whichowns the larger market share of over 95% for sales value in 2014. As an outstanding antibacterial drug, moxifloxacin ...

Jun, 2015 20 pages
Investigation Report on China Menotropins Market, 2010-2019 US$ 2,000.00

... Livzon Pharmaceutical, Livzon Pharmaceutical Group, Inc, Ferring Pharmaceytical Co., Ltd (Germany), Ma’anshan Fengyuan Pharmaceutical Co., Ltd, Yantai North Pharmaceutical Co., Ltd and Shanghai Livzon Pharmaceutical Co., Ltd, among which Shanghai Livzon Pharmaceutical Co., Ltd ...

Jun, 2015 30 pages
Investigation Report on China Levothyroxine Market, 2010-2019 US$ 2,000.00

... Thyroid hormones (TH) have the greatest effect of promoting growth on five-month-old babies or younger ones. Without thyroid hormones ... Levothyroxine enjoys a vast demand in China. Merck (Germany), Berlin-Chemie AG (Germany) and China Associated Pharmaceutical all take up certain market share, among which Merck ...

Jun, 2015 20 pages
Investigation Report on China Glucosamine Market, 2010-2019 US$ 2,000.00

... Glucosamine is of great demand in China. Most of the market share has been occupied by Shanxi Zhongyuanwei Pharmaceutical Co., Ltd, Bright Future Pharmaceutical Laboratories Limited, Rottapharm Ltd, Zhejiang Hisun Pharmaceutical Co., Ltd ...

Jun, 2015 35 pages
Investigation Report on China Ganglioside Market, 2010-2019 US$ 2,000.00

... ganglioside sodium in China, among which Qilu Pharmaceutical Co., Ltd, Medical University Pharmaceutical Co., Ltd, Beijing Science Sun Pharmaceutical Co., Ltd, Changchun Xiangtong Pharmaceutical Co., Ltd and Wellso Pharmaceutical take the lion’s share. The marketing of domestic ganglioside ...

Jun, 2015 35 pages
Investigation Report on China Flurbiprofen Market, 2010-2019 US$ 2,000.00

... Beijing Tide Pharmaceutical Co., Ltd and MIKASA SEIYAKU CO.,LTD, the former having the larger market share of 99% for sales value in 2014. The market size of flurbiprofen in China ...

Jun, 2015 20 pages
Investigation Report on China Etanercept Market, 2010-2019 US$ 2,000.00

... etanercept in the Chinese market is monopolized by Boehringer Ingelheim (Germany). According to CRI’s market survey, the price range of 25 mg (one injection per package) etanercept ...

Jun, 2015 20 pages
Investigation Report on China Entecavir Market, 2010-2019 US$ 2,000.00

... hepatitis B virus (HBV) exceeds 100 million in China, among which 20-30 million suffering from chronic Hepatitis B. ... entecavir in China rose from CNY 30 million in 2006 to CNY 1.207 billion in 2014 and CAGR during this period reached up to 55%. Entecavir made by Sino-American Shanghai Squibb Pharmaceuticals Ltd ...

Jun, 2015 30 pages
Investigation Report on China Cefathiamidine Market, 2010-2019 US$ 2,000.00

... Guangzhou Baiyunshan Pharmaceutical General Factory, cefathiamidine has been written into the Chinese Pharmacopoeia (2005). Ever since its marketing in 2000, the sales value of cefathiamidine ...

Jun, 2015 35 pages
Investigation Report on China Bromhexine Market, 2010-2019 US$ 2,000.00

... bromhexine in the Chinese market mainly comes from local enterprises like Jiangxi Kelun Pharmaceutical Co., Ltd, Jincheng Haisi Pharmaceutical Co., Ltd and Shanxi Powerdone Pharmaceutical Co., Ltd, Shijiazhuang No.4 Pharmaceutical Co., Ltd ...

Jun, 2015 30 pages
Cytokinetics, Inc. - Product Pipeline Review - 2015 US$ 1,500.00

... product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Cytokinetics, Inc.’s pipeline products Reasons to buy Evaluate Cytokinetics, Inc ...

May, 2015 50 pages
Burkholderia Pseudomallei Infections - Pipeline Review, H1 2015 US$ 2,000.00

... Burkholderia Pseudomallei Infections - Pipeline Review, H1 2015’, provides an overview of the Burkholderia Pseudomallei Infections’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Burkholderia Pseudomallei Infections ...

May, 2015 42 pages
Amunix Operating Inc. - Product Pipeline Review - 2015 US$ 1,500.00

... portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Amunix Operating Inc.’s pipeline ...

May, 2015 37 pages
Syphilis Global Clinical Trials Review, H1, 2015 US$ 2,500.00

... Syphilis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Syphilis . It includes an overview of the trial numbers and their recruitment ...

May, 2015 75 pages
Abscess Global Clinical Trials Review, H1, 2015 US$ 2,500.00

... clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials Facilitates clinical trial ...

May, 2015 149 pages
Infectious Diarrhea Global Clinical Trials Review, H1, 2015 US$ 2,500.00

... Infectitious Diarrhea clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Infectitious Diarrhea . It includes an overview of the trial numbers and their recruitment ...

Apr, 2015 68 pages
Ileus (Intestinal Obstruction) Global Clinical Trials Review, H1, 2015 US$ 2,500.00

Ileus (Intestinal Obstruction) Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Ileus (Intestinal Obstruction) Global Clinical Trials Review, H1, 2015' provides data on the Ileus (Intestinal Obstruction) clinical trial ...

Apr, 2015 80 pages
Gastric Ulcers Global Clinical Trials Review, H1, 2015 US$ 2,500.00

... Gastric Ulcers clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gastric Ulcers. It includes an overview of the trial numbers and their recruitment ...

Apr, 2015 91 pages
Functional (Non Ulcer) Dyspepsia Global Clinical Trials Review, H1, 2015 US$ 2,500.00

... clinical trial report, “Functional (Non Ulcer) Dyspepsia Global Clinical Trials Review, H1, 2015' provides data on the Functional (Non Ulcer) Dyspepsia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Functional (Non Ulcer) Dyspepsia ...

Apr, 2015 75 pages
1 2 3 4 5 >
Skip to top